HOME >> MEDICINE >> NEWS
Studies show antidepressants not linked to birth defects

WHITE PLAINS, N.Y., JUNE 27, 2007 -- Two research studies published today in The New England Journal of Medicine found taking SSRIs (selective serotonin reuptake inhibitors), anti-depression drugs, during pregnancy did not significantly increase the overall risk for most birth defects. However, each study found that taking SSRIs during pregnancy was associated with a small increase in the risk of certain rare birth defects but they were different birth defects.

Dr. Michael Katz, acting Medical Director of the March of Dimes, said the studies show how important post-market surveillance is in assessing the safety of medications in pregnancy. During pre-approval, drugs are tested on relatively few subjects and only side effects with a large frequency are detected. Once approved, many people take the medication and even very rare side effects surface.

Most prescription drugs are not tested on pregnant women, said Dr. Katz. So we must start monitoring the effects of these medications as soon as they reach consumers, and keep monitoring for as long as it takes to get good data on risks to mothers and babies.

The March of Dimes recommends women discuss the potential risks and benefits of taking SSRIs during pregnancy with their doctors. Women who are taking an antidepressant should not stop taking their medications if they discover they are pregnant, but should immediately contact their health care provider. It may be dangerous to stop taking an antidepressant suddenly.

About 10 percent of pregnant women in the United States suffer from depression, some of it undiagnosed.

Previous studies have found that some SSRIs may increase the risk for other problems for babies, including:

  • Withdrawal symptoms in newborns;

  • Pulmonary hypertension of the newborn (PPHN), a rare, but serious heart and lung disorder;

  • Low birthweight or preterm delivery.


'"/>

Contact: Elizabeth Lynch
elynch@marchofdimes.com
914-997-4286
March of Dimes Foundation
3-Jul-2007


Page: 1

Related medicine news :

1. Studies show role of age, gender, race and weight on cancer risk and treatment
2. Studies suggest investigational agent reduces disease activity in MS
3. Studies highlight advances in diagnosis, medical therapy
4. Studies highlight real world use, safety of drug-eluting stents
5. Studies led by Rhode Island Hospital confirm safety and efficacy
6. Studies identify food sources of disease and drug resistance
7. Studies provide new evidence on risks associated with Cox-2 inhibitors and NSAIDs
8. Studies highlight need to monitor heart function in breast cancer patients
9. Studies examine physician disclosure of medical errors
10. Studies indicate medication can be an effective therapy for smoking cessation
11. Studies evaluating health effects of dental amalgam fillings in children confirm safety

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/14/2020)... ... February 14, 2020 , ... Cloudticity announced today it ... company’s support for healthcare organizations using Amazon Web Services (AWS). , “Our customers ... experience to do so,” explained Cloudticity Founder & CEO, Gerry Miller. “In service ...
(Date:2/13/2020)... , ... February 13, 2020 , ... ... locations in Northern Virginia: Arlington, Dulles-Aldie, Fair Oaks, Fairfax, Fredericksburg, Leesburg, and Woodbridge, ... eight D.C.- and Virginia-based fertility specialists have been named as Top Docs for ...
(Date:2/11/2020)... ... February 11, 2020 , ... Soterius, Inc., ... announced its move to a new, significantly larger business premises in Lawrenceville, NJ. ... expansion in the development of digital technology platforms. , “As our customer base ...
(Date:2/10/2020)... PASADENA, Calif. (PRWEB) , ... February 10, 2020 , ... ... experience sensitivity in their teeth in certain situations. The answer is that – not ... or harsh forces – pain and sensitivity serve as an alert to potential damage ...
(Date:2/10/2020)... ... February 10, 2020 , ... Terry Savage ... been elected president of the Society for Health Communication for 2020. ... and implement award-winning, research-driven Federal social marketing campaigns and health education programs that ...
Breaking Medicine News(10 mins):
(Date:2/10/2020)... ... February 11, 2020 , ... FDA Data Integrity, ... Cerulean Associates LLC and FDAnews, March 17-18, 2020, Doubletree Hotel Philadelphia Center City ... Data Integrity: For Device and Pharma Firms, and Their Suppliers Workshop ends on ...
(Date:2/10/2020)... N.C. (PRWEB) , ... February 10, 2020 , ... A ... It’s called Hush Buddy -- a patented sleep training system for children, launching ... and their parents. , With the Hush Buddy Sleep System, getting a child to ...
(Date:2/10/2020)... ... 2020 , ... SentryHealth announced today the expansion ... clinics. Focused on leading innovation in the treatment of chronic disease, Healthstat will ... employee health clinics. Healthward delivers greater insight into eligibility for chronic care management ...
Breaking Medicine Technology:
Cached News: